Outpost Bio

Outpost

The company develops microbiome models using machine learning to help drug and food research teams predict biological interactions and assess development risks.

Anto

This company develops foundation models to predict drug toxicity and efficacy by analysing gut microbiome data for pharmaceutical firms and drug developers.

Anto Biosciences

This company develops foundation models for microbial communities to predict drug toxicity and efficacy for pharmaceutical and biotechnology researchers.

Pragma Biosciences

This company develops a drug discovery platform using machine learning to identify microbiome-derived small molecules for pharmaceutical and healthcare partners.

Pragma Bio

This company develops a machine learning platform to discover and manufacture microbiome-derived small molecule medicines for patients with immunological disorders and cancer.

BioCorteX

This digital medicine company develops a simulation platform to model drug-microbiome interactions for pharmaceutical and biotechnology clients to improve treatment outcomes.

Concerto BioSciences

This company develops microbe-based ingredients and therapeutics for skincare and healthcare companies using a combinatorial screening platform to map microbial interactions.

Nexilico

This company develops a computational discovery platform for precision microbiome engineering to help pharmaceutical firms and healthcare providers design targeted therapies and personalised treatments.